DNA Electronics Appoints Nick McCooke as Chief Business Officer
News Jun 10, 2014
DNA Electronics Ltd (DNAe) has announced the appointment of Nick McCooke as Chief Business Officer as it continues to build its management team.
Mr McCooke brings 30 years of senior management experience in Healthcare businesses. As CEO of Solexa, from its spin-out from the University of Cambridge in 2000 to its NASDAQ listing in 2005, he led the development of the world’s leading Next Generation DNA Sequencing (NGS) technology, which is the basis of Illumina’s current product line.
Mr McCooke comments: “I’m thrilled to be joining DNAe at this exciting point in the company’s evolution. I was proud to be part of the NGS revolution ten years ago and I believe that bringing the technology to clinicians at the point of need is the next revolution.”
CEO and Chairman Prof. Chris Toumazou adds: “This is a key appointment for DNAe, as we build a world-class management team to bring our Genalysis® molecular diagnostics platform to market. Nick’s experience, both in NGS technology and in the diagnostics markets will help us to develop ground-breaking new products that give clinicians rapid actionable diagnosis of life-threatening conditions.”
Shire, Microsoft and EURORDIS Form Global Commission to Accelerate Rare Disease DiagnosisNews
The alliance aims to shorten the often multi-year journey that patients and families endure before being diagnosed with a rare disease.READ MORE
RNA That Helps Grow Blood Vessels Could Aid Heart Disease ResearchNews
STEEL, a noncoding RNA, acts on genes to stimulate produce of blood vessels, a finding which could advance efforts to combat heart disease.READ MORE
Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast CancerNews
A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018